Skip to main content
Veterinary Medicines

MILBEMAX 16 MG/40 MG FILM-COATED TABLETS FOR CATS

Authorised
  • Milbemycin oxime
  • Praziquantel

Product identification

Medicine name:
MILBEMAX 16 MG/40 MG FILM-COATED TABLETS FOR CATS
Milbemax filmomhulde tabletten voor katten
Active substance:
  • Milbemycin oxime
  • Praziquantel
Target species:
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Milbemycin oxime
    16.00
    milligram(s)
    /
    1.00
    Tablet
  • Praziquantel
    40.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Film-coated tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AB51
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Available in:
  • Netherlands
Package description:
  • Box of 1 PVC/PE/PVdC/aluminium blisters of 2 tablets
  • Box of 10 PVC/PE/PVdC/aluminium blisters of 10 tablets
  • Box of 5 PVC/PE/PVdC/aluminium blisters of 10 tablets
  • Box of 2 PVC/PE/PVdC/aluminium blisters of 10 tablets
  • Box of 1 PVC/PE/PVdC/aluminium blisters of 10 tablets
  • Box of 1 PVC/PE/PVdC/aluminium blisters of 4 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Elanco France S.A.S.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 10093
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0135/004
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Czechia
  • Denmark
  • Finland
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 30/06/2025